Resources

We cover the UK's new Industrial Strategy and its implications for the life sciences, while also monitoring global developments, such as recent US trade policy and the acquisition of UK companies.

In the third instalment of our updates on new Government policy, Lewis Miles and Maddie Cass from BIA’s Policy and Public Affairs team take a deep dive into the Industrial Strategy and the Digital and Technologies Sector Plan, breaking down the implications for engineering biology and the wider life sciences sector.  

In this blog, Emma Lawrence, Head of Data Tech Policy and Public Affairs at BIA, explains why BIA is publishing a health data access industry checklist to support data access.

In this blog, Charlotte shares how her experience as a mentee on the BIA’s Women in Biotech mentoring programme helped her build confidence, embrace her leadership style, and navigate the challenges of a growing career in biotech. 

In the second instalment of our blog series on new government policy, Lewis Miles and Linda Bedenik examine the UK's Trade and National Security strategies and what they mean for biotech.

In a shifting global landscape, we break down how the UK's new Trade and National Security strategies aim to future-proof our biotech sector.

This is the first-ever autoimmunity study to evaluate a potential functional cure that targets the antigenic source – the origin of autoimmune disease.

First non-hormonal menopause treatment approved for use in the UK by the MHRA, with early-stage development at Stevenage Bioscience Catalyst

Research conducted by Pioneer Group in collaboration with Beauhurst into the UK life sciences landscape reveals a growing trend of investment into more mature companies.

Discovery Park has partnered with global proptech leader Equiem to launch Discover More — a purpose-built app that redefines how people work, connect, and collaborate across the 220-acre site. Home to over 180 pioneering companies working across science and technology, the new app is designed to make every tenant’s day-to-day experience more efficient and better connected, supporting an active tenant community and innovation ecosystem.

Microbiotica announces that patient recruitment is complete in its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis (UC) patients.

Call for BIA Board candidates. We are delighted to invite nominations from individuals interested in joining the BIA Board.

Cotton Mouton Diagnostics (CMD), a cutting-edge UK-based diagnostics technology company, has received a half-a-million-pound investment from CPI Enterprises as part of the Innovate UK Catapult Investment Pilot.

Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, has announced the appointment of Anna Griffin as Chief Financial Officer, filling a key leadership role within the company following its recent £14 million Series C funding round.

The BioIndustry Association (BIA) is now inviting applications for its 2026 Charity Partnership.

Rosalind brings extensive leadership experience across the health and life sciences sector. She has led the Government’s Office for Life Sciences for the last four years, bringing together the Government, the NHS, academia and industry to drive improved patient outcomes and economic growth through life sciences.

 In this blog, Abby Clark builds on a round table the BIA hosted with Chi Onwurah MP and Newcastle life science companies to explore the landscape and the drivers which make the sector strong, yet undervalued. 

LIfT BioSciences ('LIfT' or 'the Company')today announces a grant of €12 million has been awarded from Ireland's Disruptive Technologies Innovation Fund

Members of the Industry Skills Accelerator (ISA) have celebrated a successful year of strengthening the UK’s medicines manufacturing workforce.

We're pleased to announce the appointment of Livija Deban, Chief Scientific Officer at Prokarium, as Chair of its Engineering Biology Advisory Committee (EBAC).